Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $67.26 USD
Change Today +0.97 / 1.46%
Volume 600.1K
Q On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

quintiles transnational hold (Q) Snapshot

Open
$66.30
Previous Close
$66.29
Day High
$67.37
Day Low
$66.25
52 Week High
03/24/15 - $68.52
52 Week Low
04/30/14 - $46.27
Market Cap
8.4B
Average Volume 10 Days
570.9K
EPS TTM
$2.70
Shares Outstanding
124.8M
EX-Date
--
P/E TM
25.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for QUINTILES TRANSNATIONAL HOLD (Q)

quintiles transnational hold (Q) Related Businessweek News

No Related Businessweek News Found

quintiles transnational hold (Q) Details

Quintiles Transnational Holdings Inc., through its subsidiary, Quintiles Transnational Corp., provides biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through two segments, Product Development and Integrated Healthcare Services. The Product Development segment offers project management and clinical monitoring services, including study design and operational planning, investigator/site recruitment, site and regulatory start up, patient recruitment, clinical monitoring, and project management for conducting various multi-site trials; and clinical trial support services comprising clinical data management, biostatistical, central laboratories, genomic laboratory, bioanalytical laboratories, cardiac safety and ECG, safety and pharmacovigilance, and phase I clinical pharmacology services. This segment also provides strategic planning and design services for biomarkers, genomics, and personalized medicine, as well as offers model-based drug development and regulatory affairs services; and consulting services, such as product development strategy, regulatory and compliance, and process and IT implementation consulting services. The Integrated Healthcare Services segment offers commercial services comprising contract sales, market entry/market exit, integrated channel management, patient engagement, and market access and commercialization consulting services; real-world late phase services, such as observational studies, comparative effectiveness studies, and product and disease registry services; and communication and health engagement services, including digital patient, and brand and scientific communications services. The company serves biopharmaceutical companies, including medical device and diagnostics companies. Quintiles Transnational Holdings Inc. was founded in 1982 and is based in Durham, North Carolina.

32,600 Employees
Last Reported Date: 03/16/15
Founded in 1982

quintiles transnational hold (Q) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $1.0M
Executive Chairman
Total Annual Compensation: $800.0K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $580.0K
Executive Vice President, General Counsel and...
Total Annual Compensation: $434.4K
Compensation as of Fiscal Year 2014.

quintiles transnational hold (Q) Key Developments

Quintiles Transnational Seeks Acquisitions

Quintiles Transnational Holdings Inc. (NYSE:Q)'s Chief Executive Officer Tom Pike said, "We also are looking for non-US-based acquisitions, clearly a priority over time. In addition, we look at analytical areas, so in the IHS segment, for instance, to supplement the market-access capabilities that we already have or to supplement our real-world [late phase] capabilities, we would look for more analytically oriented acquisitions. So we continue to look around the world."

Quintiles Transnational Holdings Inc. Presents at 3rd Annual Regen Med Investor Day, Mar-25-2015 08:55 AM

Quintiles Transnational Holdings Inc. Presents at 3rd Annual Regen Med Investor Day, Mar-25-2015 08:55 AM. Venue: Metropolitan Club, One East 60th Street, New York, NY 10022, United States. Speakers: John Doyle, SVP & Managing Director, Global Market Access & Commercial.

Quintiles Transnational Holdings Inc. Presents at Barclays Global Healthcare Conference, Mar-10-2015 11:15 AM

Quintiles Transnational Holdings Inc. Presents at Barclays Global Healthcare Conference, Mar-10-2015 11:15 AM. Venue: Loews Miami Beach Hotel, 1601 Collins Avenue, Miami, Florida, United States. Speakers: Thomas H. Pike, Chief Executive Officer and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
Q:US $67.26 USD +0.97

Q Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Charles River Laboratories International Inc $79.61 USD +0.60
ICON PLC $70.46 USD +0.85
IMS Health Holdings Inc $26.75 USD +0.20
INC Research Holdings Inc $31.94 USD -0.07
PAREXEL International Corp $68.38 USD +0.78
View Industry Companies
 

Industry Analysis

Q

Industry Average

Valuation Q Industry Range
Price/Earnings 24.7x
Price/Sales 2.0x
Price/Book NM Not Meaningful
Price/Cash Flow 23.6x
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QUINTILES TRANSNATIONAL HOLD, please visit www.quintiles.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.